Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)

William G Dixon(University of Manchester), Deborah Symmons(MRC Epidemiology Unit)

Annals of the Rheumatic Diseases

October 24, 2009

10.1136/ard.2009.118935

Cited by 708

Related Papers

High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis

|Nature Genetics|2012|677

Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

|Annals of the Rheumatic Diseases|2016|331

A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort study

|BMJ|1996|100

The Association between Systemic Glucocorticoid Use and the Risk of Cataract and Glaucoma in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

|PLoS ONE|2016|50

Half of UK patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: a retrospective drug utilisation study

|Arthritis Research & Therapy|2015|31